Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women

Hepatology

Volumn 56, Issue 5, 2012, Pages 1699-1705

  Sarkar, Monika ^a   Bacchetti, Peter ^a   French, Audrey L ^b   Tien, Phyllis ^a   Glesby, Marshall J ^c   Nowicki, Marek ^d   Plankey, Michael ^e   Gange, Stephen ^f   Sharp, Gerald ^g   Minkoff, Howard ^h   Peters, Marion G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Jr Hospital of Cook County   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HEPATITIS C; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; SELF REPORT; SURVIVAL;

ADULT; AFRICAN AMERICANS; CD4 LYMPHOCYTE COUNT; COINFECTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPACIVIRUS; HEPATITIS C; HISPANIC AMERICANS; HIV; HIV INFECTIONS; HUMANS; LIVER DISEASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RNA, VIRAL; UNITED STATES;

EID: 84868204307     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25859     Document Type: Article

References (25)

1. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. HEPATOLOGY 2009; 49: 1335-1374.
2. Edlin BR. Perspective: test and treat this silent killer. Nature 2011; 474: S18-S19.
3. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138: 197-207.
4. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
5. Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat 2007; 14: 107-115.
6. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-1569.
7. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. HEPATOLOGY 2004; 39: 476-483.
8. Pearlman BL. Hepatitis C virus infection in African Americans. Clin Infect Dis 2006; 42: 82-91.
9. Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, et al. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clin Gastroenterol Hepatol 2008; 6: 1403-1411.
10. Crosse K, Umeadi OG, Anania FA, Laurin J, Papadimitriou J, Drachenberg C, Howell CD. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol 2004; 2: 463-468.
11. Harzke AJ, Baillargeon JG, Kelley MF, Diamond PM, Goodman KJ, Paar DP. HCV-related mortality among male prison inmates in Texas, 1994-2003. Ann Epidemiol 2009; 19: 582-589.
12. Rosen DL, Schoenbach VJ, Wohl DA. All-cause and cause-specific mortality among men released from state prison, 1980-2005. Am J Public Health 2008; 98: 2278-2284.
13. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. HEPATOLOGY 2008; 47: 1128-1135.
14. Merriman NA, Porter SB, Brensinger CM, Reddy KR, Chang KM. Racial difference in mortality among U.S. veterans with HCV/HIV coinfection. Am J Gastroenterol 2006; 101: 760-767.
15. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9: 117-125.
16. Varadhan R, Weiss CO, Segal JB, Wu AW, Scharfstein D, Boyd C. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care 2010; 48: S96-S105.
17. Sugimoto K, Stadanlick J, Ikeda F, Brensinger C, Furth EE, Alter HJ, Chang KM. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. HEPATOLOGY 2003; 37: 590-599.
18. Bonacini M, Groshen MD, Yu MC, Govindarajan S, Lindsay KL. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 2001; 96: 2438-2441.
19. Kohla M, Iwata S, Ea R, Keyhan S, Taylor R, Yu MC, et al. Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter? Dig Dis Sci 2012; 57: 771-776.
20. Verma S, Bonacini M, Govindarajan S, Kanel G, Lindsay KL, Redeker A. More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol 2006; 101: 1817-1823.
21. Barreiro P, Pineda JA, Rallon N, Naggie S, Martin-Carbonero L, Neukam K, et al. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. J Infect Dis 2011; 203: 1629-1636.
22. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
23. Lutz P, Wasmuth JC, Nischalke HD, Vidovic N, Grunhage F, Lammert F, et al. Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene. Eur J Med Res 2011; 16: 335-341.
24. Marabita F, Aghemo A, De Nicola S, Rumi MG, Cheroni C, Scavelli R, et al. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection. HEPATOLOGY 2011; 54: 1127-1134.
25. Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, et al. Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. J Clin Immunol 2011; 31: 891-899.